Loading...

CGON CG ONCOLOGY INC Management Changes 8-K Filing

CG N

CGN

CG ONCOLOGY INC

(CGON)

2025 8-K

Show Summary

Summary

Corporate Presentation Update

Clinical Trial Update

Financial Statements

Appointed Directors

Financial Statements

Product Expansion

Financial Results

Clinical Trial Update

Executive Agreements

Clinical Trial Results

Financial Results

External Links:

On July 7, 2025, Corleen Roche resigned as CFO of CG Oncology, effective August 5, 2025, and Robert Lapetina was appointed as interim principal financial and accounting officer starting the same day.

AI Assistant

CG ONCOLOGY INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.